Go to content
|
Go to main menu
About
Data sources and methodology
Interactive analyses
Analyses and publications
Data
cs
General info
History
Involved subjects and contact
Calendar
Links
Data sources
Classifications
Methods of data analysis
Limitations
International comparison
Publications
Open data
Data summaries
Incidence
Mortality
Incidence and mortality
Prevalence
Survival
Help
Year
Prevalence of persons
1990
158,183
1991
167,248
1992
177,637
1993
189,066
1994
201,523
1995
213,771
1996
227,273
1997
240,749
1998
253,709
1999
266,954
2000
280,179
2001
294,109
2002
308,324
2003
323,446
2004
339,336
2005
356,306
2006
372,680
2007
391,075
2008
408,789
2009
426,519
2010
445,924
2011
464,146
2012
482,776
2013
502,058
2014
522,232
2015
542,422
2016
562,925
2017
581,354
2018
597,945
2019
616,931
2020
627,067
2021
638,272
2022
657,757
Analysis settings
Stratification
By year
By sex
By age
By region
By cancer type
By age and cancer type
Type of neoplasm
MALIGNANT NEOPLASMS (C00–C97)
MALIGNANT NEOPLASMS EXCLUDING OTHER MALIGNANT NEOPLASMS OF SKIN (C00–C97 EXCLUDING C44)
NEOPLASMS OF HEAD AND NECK
Malignant neoplasms of head and neck (C00–C14, C30–C31)
Malignant neoplasm of lip (C00)
Malignant neoplasm of base of tongue (C01)
Malignant neoplasm of other and unspecified parts of tongue (C02)
Malignant neoplasm of gum (C03)
Malignant neoplasm of floor of mouth (C04)
Malignant neoplasm of palate (C05)
Malignant neoplasm of other and unspecified parts of mouth (C06)
Malignant neoplasm of parotid gland (C07)
Malignant neoplasm of other and unspecified major salivary glands (C08)
Malignant neoplasm of tonsil (C09)
Malignant neoplasm of oropharynx (C10)
Malignant neoplasm of nasopharynx (C11)
Malignant neoplasm of piriform sinus (C12)
Malignant neoplasm of hypopharynx (C13)
Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx (C14)
Malignant neoplasm of nasal cavity and middle ear (C30)
Malignant neoplasm of accessory sinuses (C31)
Malignant neoplasm of eye and adnexa (C69)
NEOPLASMS OF DIGESTIVE ORGANS
Malignant neoplasm of oesophagus (C15)
Malignant neoplasm of stomach (C16)
Malignant neoplasm of small intestine (C17)
Malignant neoplasms of colon, rectosigmoid junction and rectum (C18–C20)
Malignant neoplasm of colon (C18)
Malignant neoplasm of rectosigmoid junction (C19)
Malignant neoplasm of rectum (C20)
Malignant neoplasm of anus and anal canal (C21)
Malignant neoplasm of liver and intrahepatic bile ducts (C22)
Hepatocellular carcinoma (C22)
Cholangiocarcinoma and other carcinomas of the liver (C22)
Other malignant neoplasms of liver (C22)
Unknown/unspecified (C22)
Malignant neoplasms of gallbladder and biliary tract (C23, C24)
Malignant neoplasm of gallbladder (C23)
Malignant neoplasm of other and unspecified parts of biliary tract (C24)
Malignant neoplasm of pancreas (C25)
Malignant neoplasm of other and ill-defined digestive organs (C26)
NEOPLASMS OF RESPIRATORY AND INTRATHORACIC ORGANS
Malignant neoplasm of nasal cavity and middle ear (C30)
Malignant neoplasm of accessory sinuses (C31)
Malignant neoplasm of larynx (C32)
Malignant neoplasms of trachea, bronchus and lung (C33, C34)
Malignant neoplasm of trachea (C33)
Malignant neoplasm of bronchus and lung (C34)
Squamous cell lung carcinoma (SCC) (C34)
Lung adenocarcinoma (AC) (C34)
Large-cell lung carcinoma (LCC) (C34)
Small-cell lung carcinoma (SCLC) (C34)
Another specified malignant neoplasm of lung (C34)
Unknown/unspecified (C34)
Malignant neoplasm of thymus (C37)
Malignant neoplasm of heart, mediastinum and pleura (C38)
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs (C39)
Malignant neoplasm of bone and articular cartilage of other and unspecified sites (C41)
NEOPLASMS OF SKIN
Malignant melanoma of skin (C43)
NEOPLASMS OF BONE AND ARTICULAR CARTILAGE
Malignant neoplasms of bone and articular cartilage (C40–C41)
Other malignant neoplasms of skin (C44)
Malignant neoplasm of bone and articular cartilage of limbs (C40)
NEOPLASMS OF SOFT TISSUE
Malignant neoplasm of other connective and soft tissue (C49)
NEOPLASMS OF BREAST
Malignant neoplasm of breast (C50)
NEOPLASMS OF FEMALE GENITAL ORGANS
Malignant neoplasm of vulva (C51)
Malignant neoplasm of vagina (C52)
Malignant neoplasm of cervix uteri (C53)
Malignant neoplasm of uterus (C54, C55)
Malignant neoplasm of corpus uteri (C54)
Malignant neoplasm of uterus, part unspecified (C55)
Malignant neoplasm of ovary (C56)
Malignant neoplasm of other and unspecified female genital organs (C57)
Malignant neoplasm of placenta (C58)
NEOPLASMS OF MALE GENITAL ORGANS
Malignant neoplasm of penis (C60)
Malignant neoplasm of prostate (C61)
Malignant neoplasm of testis (C62)
Seminomatous germ cell tumour (SGCT) (C62)
Non-seminomatous germ cell tumour (NSGCT) (C62)
Other malignant neoplasms of testis (C62)
Unknown/unspecified (C62)
Malignant neoplasm of other and unspecified male genital organs (C63)
NEOPLASMS OF URINARY TRACT
Malignant neoplasm of kidney, except renal pelvis (C64)
Renal cell carcinoma (C64)
Other malignant neoplasms of kidney (C64)
Unknown/unspecified (C64)
Malignant neoplasm of renal pelvis (C65)
Malignant neoplasm of ureter (C66)
Malignant neoplasm of bladder (C67)
Malignant neoplasm of other and unspecified urinary organs (C68)
NEOPLASMS OF CENTRAL NERVOUS SYSTEM AND EYE
Malignant neoplasm of brain, spinal cord and other parts of central nervous system (C70–C72)
Malignant neoplasm of meninges (C70)
Malignant neoplasm of brain (C71)
Glioblastoma (C71)
Another malignant neoplasm of brain (C71)
Unknown/unspecified (C71)
Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (C72)
NEOPLASMS OF ENDOCRINE GLANDS
Malignant neoplasm of thyroid gland (C73)
Malignant neoplasm of adrenal gland (C74)
Malignant neoplasm of other endocrine glands and related structures (C75)
NEOPLASMS OF THE BLOOD AND IMMUNE SYSTEM
NEOPLASMS OF THE BLOOD AND IMMUNE SYSTEM (C81–C96, D45–D47)
Hodgkin lymphoma (C81)
Non-Hodgkin lymphomas (C81–C86)
Multiple myeloma and malignant plasma cell neoplasms (C90)
Leukaemias (C91–C95)
Acute lymphoblastic leukemia (C91.0)
Chronic lymphocytic leukaemia (C91.1)
Acute myeloid leukaemia (C92.0, C92.4,C92.5, C93.0, C94.0, C94.2)
Chronic myeloid leukaemia (C92.1)
Polycythaemia vera (D45)
Myelodysplastic syndromes (D46)
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue (D47)
OTHER MALIGNANT NEOPLASMS
Malignant neoplasms of ill-defined, secondary and unspecified sites (C76–C80)
Malignant neoplasms of independent (primary) multiple sites (C97)
IN SITU NEOPLASMS
In situ neoplasms (D00–D09)
NEOPLASMS OF UNCERTAIN OR UNKNOWN BEHAVIOUR (D37–D48)
Sex
man
woman
Region
The entire Czech Republic
Prague
Central Bohemian Region
South Bohemian Region
Plzen Region
Karlovy Vary Region
Usti nad Labem Region
Liberec Region
Hradec Kralove Region
Pardubice Region
Vysocina Region
South Moravia Region
Olomouc Region
Zlin Region
Moravian Silesian Region
From age
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85+
To age
4
9
14
19
24
29
34
39
44
49
54
59
64
69
74
79
84
85+
From year
To year
Computational method
Absolute numbers
Rate per 100,000 population
Chart settings
Comparison of men and women
Combine years
Ano/ne
Yes
No
Show
Clear filters
Export as PNG
Export as XLSX
Prevalence. Applied filters
:
Cancer type:
MALIGNANT NEOPLASMS (C00–C97)
Region:
the entire Czech Republic
|
Range:
1990–2022
Computational method:
Prevalence of persons
Data source:
CNCR